Canine CMSD could serve as a valuable model to elucidate the mechanisms underlying SERAC1-deficiency disorders and to evaluate potential therapeutic interventions. The gene discussed is SERAC1; the disease is hyperinsulinemic hypoglycemia, familial, 4.